Falconer- Thanks for your enlightening analysis. Just another validation for 2-73 and another rare indication. Very encouraging for me. I cannot imagine why 2-73 would not get approved. I believe it will, and much sooner than many can imagine. This info bodes well in fortifying 2-73 to big pharma. We are not SMALL POTATOES anymore!!!!